Inflammatory and nutritional serum markers as predictors of peri-operative morbidity and survival in ovarian cancer

Anticancer Research

Volumn 37, Issue 7, 2017, Pages 3673-3677

  Kumar, Amanika ^a   Torres, Michelle L ^a   Cliby, William A ^a   Kalli, Kimberly R ^b   Bogani, Giorgio ^c   Aletti, Giovanni ^c   Nitschmann, Caroline C ^a   Multinu, Francesco ^a   Weaver, Amy L ^a   Block, Matthew S ^b   Mariani, Andrea ^a  

^a MAYO CLINIC   (United States)

^b Medical Oncology   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Albumin; CRP; Frailty; IL6; Malnutrition; Ovarian cancer

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR MARKER; SERUM ALBUMIN;

ADVANCED CANCER; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CENTER; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CYTOREDUCTIVE SURGERY; FEMALE; FRAILTY; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALNUTRITION; MORBIDITY; NURSING HOME; NUTRITIONAL ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL PREDICTION; TERTIARY CARE CENTER; BLOOD; INFLAMMATION; METABOLISM; NUTRITIONAL STATUS; OVARIAN NEOPLASMS; PERIOPERATIVE PERIOD; PHYSIOLOGY;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; NUTRITIONAL STATUS; OVARIAN NEOPLASMS; PERIOPERATIVE PERIOD; PILOT PROJECTS; SERUM ALBUMIN;

EID: 85021832525     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanreS.11738     Document Type: Article

References (20)

1. Robinson TN, Wallace JI, Wu DS, Wiktor A, Pointer L, Pfister S, Sharp T, Buckley M and Moss M: Accumulated frailty characteristics predict postoperative discharge institutionalization in the geriatric patient. J Am Coll Surg 213(1): 37-42, 2011.
2. Kumar A, Janco. JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver. AL, McGree ME and Cliby WA: Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer Gynecol Oncol 140(1): 15-21, 2015.
3. Erekson E, Ratner E, Walke L and Fried T: Gynecologic Surgery in the geriatric patient. Obstet Gynecol 119(6): 1262-1269, 2012.
4. AlHilli MM, Tran C, Langstraat CL, Martin J, Weaver AL, McGree ME, Mariani A, Cliby WA and Bakkum-Gamez JN: Risk-scoring model for prediction of non-home discharge in epithelial ovarian cancer patientS. J AmColl Surg 217(3): 507-515, 2013.
5. Sharma R, Hook J, Kumar M and Gabra H: Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 44(2): 251-256, 2008.
6. McMillan DC: The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treat Rev 39(5): 534-540, 2013.
7. Saito K, Kawakami S, Ohtsuka Y, Fujii Y, Masuda H, Kumagai J, Kobayashi T, Kageyama Y and Kihara K: The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. BJU Int 100(2): 269-273, 2007.
8. Dobrzycka B, Mackowiak-Matejczyk B, Kulesza-Bronczyk B, Terlikowska KM, Kinalski M and Terlikowski SJ: Serum levels of IL6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer. Eur Cytokine Netw 24(3): 106-113, 2013.
9. Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, Okuda H and Kudo T: Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 82(2): 107-110, 1998.
10. Lambeck A, Crijns A, Leffers N, Sluiter WJ, ten Hoor KA, Braid M, van der Zee. A, Daemen T, Nijman HW and Kast WM: Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: A potential role for Interleukin-7. Clin Cancer Res 13(8): 2385-2391, 2007.
11. Strasberg SM, Linehan DC and Hawkins WG: The Accordion Severity Grading System of Surgical ComplicationS. Ann Surg 250(2): 177-186, 2009.
12. Walston J, Hadley EC, Ferrucci L, Guralnik J, Newman AB, Studenski SA, Ershler WB, Harris T and Fried LP: Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older AdultS. J Am Geriatr Soc 54(6): 991-1001, 2006.
13. Yao X, Li H and Leng S: Inflammation and immune system alterations in frailty. Clin Geriatr Med 27(4): 79-87, 2009.
14. Harris TB, Ferrucci L, Corti MC, Tracy RP, Wacholder S, Ettinger WH, Heimovitz H, Cohen HJ and Wallace R: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106(2): 506-512, 1999.
15. Maggio M, Guralnik JM, Longo DL and Ferrucci L: Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol 61A(6): 575-584, 2006.
16. Puts MTE, Visser M, Twisk JWR, Deeg DJ and Lips P: Endocrine and inflammatory markers as predictors of frailty. Clin Endocrinol 63(6): 403-411, 2005.
17. Ferrucci L, Penninx B, Volpato S, Harris T, Bandeen-Roche K and Balfour J, Leveille S, Fried L and Guralnik J: Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levelS. J Am Geriatr Soc 50(12): 1947-1954, 2002.
18. Langstraat CL, Aletti GD and Cliby WA: Morbidity, mortality, and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol Oncol 123(2): 187-191, 2011.
19. Maccio AEA, Lai P, Santona MC, Pagliara L, Melis GB and Mantovani G: High serum levels of soluble IL-2 receptor. cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer. Gynecol Oncol 69(5): 248-252, 1998.
20. Kolomeyevskaya N, Eng KH, Khan ANH, Grzankowski KS, Singel KL, Moysich K and Segal BH: Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer. Gynecol Oncol 138(5): 352-357, 2015.